Alaunos Therapeutics, Inc. (TCRT) SEC Filings & Financial Intelligence
Alaunos Therapeutics, Inc. (TCRT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TCRT
CIK: 1107421
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerChristopher Rux
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-15 | — | SCHEDULE 13D/A Filing | 0001193805-26-001370 | View SEC Doc Filr Page |
| 3 | 2026-10-15 | 2026-10-13 | 3 Filing | 0001683168-26-007900 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-10-15 | — | SCHEDULE 13D Filing | 0001683168-26-007898 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001193125-26-419829 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-05 | 8-K | 0001193125-26-419154 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-417970 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-417971 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-417969 | View SEC Doc Filr Page |
| 4 | 2026-10-08 | 2026-10-06 | 4 | 0001193125-26-417974 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-18 | 8-K | 0001193125-26-397996 | View SEC Doc Filr Page |
| 424B3 | 2026-09-21 | — | 424B3 | 0001193125-26-396777 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-16 | 8-K | 0001193125-26-393462 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001193125-26-352421 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-06 | 4 | 0001193125-26-344682 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001193125-26-318114 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001193125-26-318105 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001193125-26-318103 | View SEC Doc Filr Page |
| 4 | 2026-07-27 | 2026-07-23 | 4 | 0001193125-26-318100 | View SEC Doc Filr Page |
| S-8 | 2026-07-06 | — | S-8 | 0001193125-26-295169 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 | 0001193125-26-295004 | View SEC Doc Filr Page |
| 8-K | 2026-06-29 | 2026-06-29 | 8-K | 0001193125-26-286914 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-17 | 4 | 0001193125-26-274305 | View SEC Doc Filr Page |
| 4 | 2026-05-27 | 2026-05-22 | 4 | 0001193125-26-241999 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-26 | 8-K | 0001193125-26-238237 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | 8-K | 0001193125-26-227921 | View SEC Doc Filr Page |